[The sulfanilamide resistance of patients with type-2 diabetes mellitus].
Gendeleka
G F
GF
Lakiza
V V
VV
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D000078790:Insulin Secretion; D013424:Sulfanilamides / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D013997:Time Factors
D007004:Hypoglycemic Agents; D007328:Insulin; D013424:Sulfanilamides
Sul'fanilamidorezistentnost' bol'nykh sakharnym diabetom II tipa.